{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:38:57Z","timestamp":1787027937015,"version":"build-2736575974"},"reference-count":63,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background\/Objectives: Osteoporosis is a prevalent condition characterized by reduced bone mass and microarchitectural deterioration, resulting in increased fracture risk. Ovarian cancer represents a paradigmatic model of cancer-related bone loss, owing to the combined effects of abrupt surgical menopause, chemotherapy, and tumor-driven pro-resorptive mechanisms. Methods: We conducted a narrative review of the literature on skeletal health in ovarian cancer. We synthesized current evidence on the pathogenesis, diagnostic strategies, and management of bone loss in women with ovarian cancer, with the aim of providing a disease-specific framework for clinical practice. Results: Available evidence highlights a multifactorial \u201ctriple hit\u201d to bone health in ovarian cancer: accelerated estrogen deficiency following bilateral salpingo-oophorectomy, direct tumor-derived stimulation of osteoclast activity, and chemotherapy-induced skeletal toxicity. Despite the high incidence of bone loss and fractures, systematic bone health assessment is rarely integrated into oncological care. Dual-energy X-ray absorptiometry (DXA) remains the cornerstone diagnostic tool, complemented by vertebral morphometry and fracture risk algorithms. Antiresorptive therapies, particularly bisphosphonates and denosumab, together with calcium, vitamin D, exercise, and fall-prevention strategies, have demonstrated efficacy in reducing fracture risk, although disease-specific guidelines are still lacking. Conclusions: Fracture prevention in ovarian cancer survivors is often overlooked despite its significant impact on morbidity and quality of life. Integrating bone health assessment and early antiresorptive therapy into care pathways is warranted, and future studies should develop tailored guidelines to make bone protection a key element of survivorship care.<\/jats:p>","DOI":"10.3390\/diagnostics15232966","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T10:24:17Z","timestamp":1763979857000},"page":"2966","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Osteoporosis and Fracture Risk in Ovarian Cancer: Beyond the Oncologic Burden"],"prefix":"10.3390","volume":"15","author":[{"given":"Mariagrazia Irene","family":"Mineo","sequence":"first","affiliation":[{"name":"Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties \u201cG. D\u2019Alessandro\u201d (PROMISE), Section of Endocrinology, University of Palermo, Piazza delle Cliniche 2, 90127 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6204-3423","authenticated-orcid":false,"given":"Giorgio","family":"Arnaldi","sequence":"additional","affiliation":[{"name":"Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties \u201cG. D\u2019Alessandro\u201d (PROMISE), Section of Endocrinology, University of Palermo, Piazza delle Cliniche 2, 90127 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8088-4947","authenticated-orcid":false,"given":"Valentina","family":"Guarnotta","sequence":"additional","affiliation":[{"name":"Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties \u201cG. D\u2019Alessandro\u201d (PROMISE), Section of Endocrinology, University of Palermo, Piazza delle Cliniche 2, 90127 Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00002281-200207000-00014","article-title":"Recent Developments in the Epidemiology of Osteoporosis","volume":"14","author":"Walter","year":"2002","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1186\/s13018-021-02772-0","article-title":"The Global Prevalence of Osteoporosis in the World: A Comprehensive Systematic Review and Meta-Analysis","volume":"16","author":"Salari","year":"2021","journal-title":"J. Orthop. Surg. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ecl.2012.04.006","article-title":"Pathophysiology of Osteoporosis","volume":"41","author":"Armas","year":"2012","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00198-022-06631-4","article-title":"Fracture Risk and Assessment in Adults with Cancer","volume":"34","author":"Ye","year":"2023","journal-title":"Osteoporos. Int."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e2448208","DOI":"10.1001\/jamanetworkopen.2024.48208","article-title":"Age at First Fracture and Later Fracture Risk in Older Adults Undergoing Osteoporosis Assessment","volume":"7","author":"Ye","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1007\/s00198-022-06542-4","article-title":"Fractures and Long-Term Mortality in Cancer Patients: A Population-Based Cohort Study","volume":"33","author":"Ye","year":"2022","journal-title":"Osteoporos. Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/rnj.0000000000000173","article-title":"Risk Factors for Falls in Adult Cancer Survivors: An Integrative Review","volume":"43","author":"Campbell","year":"2018","journal-title":"Rehabil. Nurs."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1007\/s00198-022-06454-3","article-title":"Global, Regional Prevalence, and Risk Factors of Osteoporosis According to the World Health Organization Diagnostic Criteria: A Systematic Review and Meta-Analysis","volume":"33","author":"Xiao","year":"2022","journal-title":"Osteoporos. Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41413-023-00306-4","article-title":"Insights and Implications of Sexual Dimorphism in Osteoporosis","volume":"12","author":"Zhang","year":"2024","journal-title":"Bone Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S8756-3282(02)00670-1","article-title":"Bone Mineral Density and Mortality in Elderly Men and Women: The Rotterdam Study","volume":"30","author":"Pols","year":"2002","journal-title":"Bone"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S2213-8587(22)00012-2","article-title":"Osteoporosis in Men","volume":"10","author":"Vilaca","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"International Osteoporosis Foundation, Borgstr\u00f6m, F., Karlsson, L., Orts\u00e4ter, G., Norton, N., Halbout, P., Cooper, C., Lorentzon, M., McCloskey, E.V., and Harvey, N.C. (2020). Fragility Fractures in Europe: Burden, Management and Opportunities. Arch. Osteoporos., 15, 59.","DOI":"10.1007\/s11657-020-0706-y"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1530\/EJE-10-0015","article-title":"Approach to the Patient with Secondary Osteoporosis","volume":"162","author":"Hofbauer","year":"2010","journal-title":"Eur. J. Endocrinol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s40520-024-02784-w","article-title":"Radiofrequency Echographic Multi Spectrometry (REMS) in the Diagnosis and Management of Osteoporosis: State of the Art","volume":"36","author":"Fuggle","year":"2024","journal-title":"Aging Clin. Exp. Res."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Lalli, P., Mautino, C., Busso, C., Bardesono, F., Di Monaco, M., Lippi, L., Invernizzi, M., and Minetto, M.A. (2022). Reproducibility and Accuracy of the Radiofrequency Echographic Multi-Spectrometry for Femoral Mineral Density Estimation and Discriminative Power of the Femoral Fragility Score in Patients with Primary and Disuse-Related Osteoporosis. J. Clin. Med., 11.","DOI":"10.3390\/jcm11133761"},{"key":"ref_16","first-page":"763","article-title":"Fragility Score: A REMS-Based Indicator for the Prediction of Incident Fragility Fractures at 5 Years","volume":"35","author":"Pisani","year":"2023","journal-title":"Aging Clin. Exp. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.spinee.2019.10.018","article-title":"Novel MRI-Based Score for Assessment of Bone Density in Operative Spine Patients","volume":"20","author":"Ehresman","year":"2020","journal-title":"Spine J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1007\/s40618-023-02056-w","article-title":"Bone Quality in Endocrine Diseases: Determinants and Clinical Relevance","volume":"46","author":"Cianferotti","year":"2023","journal-title":"J. Endocrinol. Investig."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1007\/s00586-003-0613-0","article-title":"Recognizing and Reporting Osteoporotic Vertebral Fractures","volume":"12","author":"Grigoryan","year":"2003","journal-title":"Eur. Spine J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/S0140-6736(25)01385-6","article-title":"Osteoporosis","volume":"406","author":"Ye","year":"2025","journal-title":"Lancet"},{"key":"ref_21","first-page":"12","article-title":"Cancer Statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_22","first-page":"100629","article-title":"Epithelial Ovarian Cancer: Review Article","volume":"33","author":"Sambasivan","year":"2022","journal-title":"Cancer Treat. Res. Commun."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2147\/IJWH.S197604","article-title":"Ovarian Cancer in the World: Epidemiology and Risk Factors","volume":"11","author":"Momenimovahed","year":"2019","journal-title":"Int. J. Womens Health"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk-Reducing Salpingo-Oophorectomy in Women with a BRCA1 or BRCA2 Mutation","volume":"346","author":"Kauff","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1055\/a-1545-4279","article-title":"2020 WHO Classification of Female Genital Tumors","volume":"81","author":"Brambs","year":"2021","journal-title":"Geburtshilfe Frauenheilkd."},{"key":"ref_26","unstructured":"Lele, S. (2022). Ovarian Cancer, Exon Publications."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.6004\/jnccn.2021.0007","article-title":"Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology","volume":"19","author":"Armstrong","year":"2021","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"972","DOI":"10.6004\/jnccn.2022.0047","article-title":"NCCN Guidelines\u00ae Insights: Ovarian Cancer, Version 3.2022: Featured Updates to the NCCN Guidelines","volume":"20","author":"Armstrong","year":"2022","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.critrevonc.2018.02.005","article-title":"Hormone Replacement Therapy in Cancer Survivors: Utopia?","volume":"124","author":"Angioli","year":"2018","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.maturitas.2020.01.005","article-title":"European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) Position Statement on Managing the Menopause after Gynecological Cancer: Focus on Menopausal Symptoms and Osteoporosis","volume":"134","author":"Rees","year":"2020","journal-title":"Maturitas"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1172\/JCI28550","article-title":"Estrogen Deficiency and Bone Loss: An Inflammatory Tale","volume":"116","author":"Weitzmann","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1210\/endo.142.12.8536","article-title":"Minireview: The OPG\/RANKL\/RANK System","volume":"142","author":"Khosla","year":"2001","journal-title":"Endocrinology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jbmr.1747","article-title":"ER\u03b1 Signaling Regulates MMP3 Expression to Induce FasL Cleavage and Osteoclast Apoptosis","volume":"28","author":"Garcia","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nrrheum.2010.133","article-title":"Novel Functions for NF\u03baB: Inhibition of Bone Formation","volume":"6","author":"Krum","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1172\/JCI11066","article-title":"Estrogen Deficiency Induces Bone Loss by Enhancing T-Cell Production of TNF-Alpha","volume":"106","author":"Cenci","year":"2000","journal-title":"J. Clin. Investig."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1359\/JBMR.050315","article-title":"Effect of Osteoblast-Targeted Expression of Bcl-2 in Bone: Differential Response in Male and Female Mice","volume":"20","author":"Pantschenko","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"117220","DOI":"10.1016\/j.bone.2024.117220","article-title":"Estrogen and Estrogen Receptors Mediate the Mechanobiology of Bone Disease and Repair","volume":"188","author":"Shi","year":"2024","journal-title":"Bone"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"470","DOI":"10.5468\/ogs.20012","article-title":"Effect of Gynecological Cancer and Its Treatment on Bone Mineral Density and the Risk of Osteoporosis and Osteoporotic Fracture","volume":"63","author":"Lee","year":"2020","journal-title":"Obstet. Gynecol. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1136\/ijgc-2021-003169","article-title":"Opportunistic Osteoporosis Screening Using Routine Computed Tomography Images to Identify Bone Loss in Gynecologic Cancer Survivors","volume":"32","author":"Sobecki","year":"2022","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ygyno.2015.06.020","article-title":"Osteoporosis Risk and Management in BRCA1 and BRCA2 Carriers Who Undergo Risk-Reducing Salpingo-Oophorectomy","volume":"138","author":"Garcia","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/gme.0b013e318239caeb","article-title":"Surgical Menopause and Nonvertebral Fracture Risk among Older US Women","volume":"19","author":"Vesco","year":"2012","journal-title":"Menopause"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Beekman, M.J., Terra, L., Stuursma, A., Heemskerk-Gerritsen, B.A.M., van Lennep, J.E.R., van Beurden, M., van Doorn, L.C., de Hullu, J.A., van Dorst, E.B.L., and Mom, C.H. (2025). Long-Term Effects of Premenopausal Risk-Reducing Salpingo-Oophorectomy on Bone Mineral Density. Osteoporosis International, Springer.","DOI":"10.1007\/s00198-025-07679-8"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ejca.2014.11.022","article-title":"Bone Mineral Density and Fractures after Risk-Reducing Salpingo-Oophorectomy in Women at Increased Risk for Breast and Ovarian Cancer","volume":"51","author":"Fakkert","year":"2015","journal-title":"Eur. J. Cancer"},{"key":"ref_44","first-page":"403","article-title":"High-Molecular-Weight Transforming Growth Factor Activity in the Urine of Patients with Disseminated Cancer","volume":"43","author":"Sherwin","year":"1983","journal-title":"Cancer Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1615\/CritRevImmunol.2018025874","article-title":"Does TNF Promote or Restrain Osteoclastogenesis and Inflammatory Bone Resorption?","volume":"38","author":"Zhao","year":"2018","journal-title":"Crit. Rev. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/jbmr.4480","article-title":"RANKL Blockade Reduces Cachexia and Bone Loss Induced by Non-Metastatic Ovarian Cancer in Mice","volume":"37","author":"Pin","year":"2020","journal-title":"J. Bone Miner. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"32s","DOI":"10.1016\/S0753-3322(00)80008-6","article-title":"Parathyroid Hormone-Related Peptide and Bone: Pathological and Physiological Aspects","volume":"54","author":"Inoue","year":"2000","journal-title":"Biomed. Pharmacother."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.bbrc.2010.03.057","article-title":"Prostaglandin E2 Modulates Components of the Wnt Signaling System in Bone and Prostate Cancer Cells","volume":"394","author":"Liu","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Essex, A.L., Pin, F., Huot, J.R., Bonewald, L.F., Plotkin, L.I., and Bonetto, A. (2019). Bisphosphonate Treatment Ameliorates Chemotherapy-Induced Bone and Muscle Abnormalities in Young Mice. Front. Endocrinol., 10.","DOI":"10.3389\/fendo.2019.00809"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0029-7844(97)00124-5","article-title":"Predictors of Bone Mineral Loss in Patients with Ovarian Cancer Treated with Anticancer Agents","volume":"90","author":"Douchi","year":"1997","journal-title":"Obstet. Gynecol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"353.e1","DOI":"10.1016\/j.ajog.2010.06.001","article-title":"Longitudinal Assessment of Bone Loss from Diagnostic Computed Tomography Scans in Gynecologic Cancer Patients Treated with Chemotherapy and Radiation","volume":"203","author":"Hui","year":"2010","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/EC-12-0043","article-title":"Bone Mineral Loss Induced by Anticancer Treatment for Gynecological Malignancies in Premenopausal Women","volume":"2","author":"Nishio","year":"2013","journal-title":"Endocr. Connect."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1200\/JCO.19.01696","article-title":"Management of Osteoporosis in Survivors of Adult Cancers With Nonmetastatic Disease: ASCO Clinical Practice Guideline","volume":"37","author":"Shapiro","year":"2019","journal-title":"JCO"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jbo.2017.03.001","article-title":"Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in Postmenopausal Women with Hormone Sensitive Breast Cancer: Joint Position Statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG","volume":"7","author":"Hadji","year":"2017","journal-title":"J. Bone Oncol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"100355","DOI":"10.1016\/j.jbo.2021.100355","article-title":"Updated Guidance on the Management of Cancer Treatment-Induced Bone Loss (CTIBL) in Pre- and Postmenopausal Women with Early-Stage Breast Cancer","volume":"28","author":"Waqas","year":"2021","journal-title":"J. Bone Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2131\/jts.37.617","article-title":"Osteosarcoma in Sprague-Dawley Rats after Long-Term Treatment with Teriparatide (Human Parathyroid Hormone (1-34))","volume":"37","author":"Watanabe","year":"2012","journal-title":"J. Toxicol. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/AOG.0000000000001396","article-title":"Hormone Use After Nonserous Epithelial Ovarian Cancer: Overall and Disease-Free Survival","volume":"127","author":"Power","year":"2016","journal-title":"Obstet. Gynecol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/(SICI)1097-0142(19990915)86:6<1013::AID-CNCR17>3.0.CO;2-1","article-title":"Estrogen Replacement Therapy for Ovarian Carcinoma Survivors: A Randomized Controlled Trial","volume":"86","author":"Guidozzi","year":"1999","journal-title":"Cancer"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2217\/fon.11.113","article-title":"Antiangiogenic Effects of Zoledronate on Cancer Neovasculature","volume":"7","author":"Metcalf","year":"2011","journal-title":"Future Oncol."},{"key":"ref_60","first-page":"116","article-title":"Prevention and Treatment of Bone Fragility in Cancer Patient","volume":"12","author":"Ottanelli","year":"2015","journal-title":"Clin. Cases Miner. Bone Metab."},{"key":"ref_61","first-page":"2113","article-title":"Safety of Denosumab in Postmenopausal Women with Osteoporosis or Low Bone Mineral Density: A Meta-Analysis","volume":"7","author":"Zhou","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_62","first-page":"24","article-title":"Bone Health: Biology and Nutrition","volume":"27","author":"Rizzoli","year":"2024","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/jc.2010-2704","article-title":"The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know","volume":"96","author":"Ross","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/23\/2966\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T10:41:58Z","timestamp":1763980918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/23\/2966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,22]]},"references-count":63,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["diagnostics15232966"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics15232966","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,22]]}}}